Exemestane and Lung infection - a phase IV clinical study of FDA data

Summary:

Lung infection is reported as a side effect among people who take Exemestane (exemestane), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Afinitor, and have Pain.

The phase IV clinical study analyzes which people have Lung infection when taking Exemestane. It is created by eHealthMe based on reports of 13,876 people who have side effects when taking Exemestane from the FDA, and is updated regularly.

What is Exemestane?

Exemestane has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 14,038 Exemestane users. Check the latest studies of Exemestane.

What is Lung infection?

Lung infection is found to be associated with 1,065 drugs and 1,316 conditions by eHealthMe. Check the latest studies of Lung infection.

On Jul, 11, 2026

13,876 people reported to have side effects when taking Exemestane.
Among them, 22 people (0.16%) have Lung infection.

Among these 22 people:

How long have people been on Exemestane when they have Lung infection? *

What is the gender of people who have Lung infection when taking Exemestane? *

female: 90 %
male: 10 %

What is the age of people who have Lung infection when taking Exemestane? *

What are other drugs people take besides Exemestane? *

What are other side effects people have besides Lung infection? *

Dyspnea (difficult or laboured breathing): 9 people, 40.91%
Fatigue (feeling of tiredness): 7 people, 31.82%
Fever: 5 people, 22.73%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 18.18%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 18.18%
Pleural Effusion (water on the lungs): 4 people, 18.18%
Pneumonia: 4 people, 18.18%
Cough: 3 people, 13.64%
Lung Disorder (lung disease): 3 people, 13.64%
Lower Respiratory Tract Infection: 3 people, 13.64%

What are the existing conditions these people have? *

Pain: 3 people, 13.64%
High Blood Cholesterol: 2 people, 9.09%
Fever: 2 people, 9.09%
Blood Potassium Decreased: 2 people, 9.09%
Oral Candidiasis (fungal infection of mouth): 2 people, 9.09%
Breast Cancer Male: 2 people, 9.09%
Breast Cancer Recurrent: 1 person, 4.55%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 4.55%
Cough: 1 person, 4.55%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Exemestane and have Lung infection?

- Check whether Lung infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exemestane:

Exemestane (14,038 reports)

Lung infection treatments and more:

Lung infection (25,183 reports)

Browse all side effects of Exemestane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung infection:

Lung infection (1,065 drugs)

Browse all the conditions that are associated with Lung infection:

Lung infection (1,316 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on exemestane (the active ingredients of Exemestane) and Exemestane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.